Takeda’s Dengue Vaccine Works Safely, Company Says - The Wall Street Journal

1. Takeda’s Dengue Vaccine Works Safely, Company Says  The Wall Street Journal
2. UPDATED: Takeda claims PhIII success in dengue vaccine months after Dengvaxia implosion for rival Sanofi  Endpoints News
3. Takeda's dengue shot, rival to Sanofi's Dengvaxia, hits the mark in massive phase 3 study  FiercePharma
4. Takeda dengue vaccine meets main goal of trial; detailed results to come  Reuters
5. Takeda's Phase III Dengue Vaccine Results Bring Them "One Step Closer" to Stopping Tropical Disease  BioSpace
6. View full coverage on Google News

(CLICK HERE TO READ AND SEE MORE)